(NASDAQ: SANA) Sana Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 58.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.75%.
Sana Biotechnology's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast SANA's revenue for 2028 to be $14,480,655,332, with the lowest SANA revenue forecast at $14,480,655,332, and the highest SANA revenue forecast at $14,480,655,332. On average, 1 Wall Street analysts forecast SANA's revenue for 2029 to be $43,802,854,602, with the lowest SANA revenue forecast at $43,802,854,602, and the highest SANA revenue forecast at $43,802,854,602.
In 2030, SANA is forecast to generate $78,809,049,423 in revenue, with the lowest revenue forecast at $78,809,049,423 and the highest revenue forecast at $78,809,049,423.